U.S. Markets closed

Such Is Life: How Chemours (NYSE:CC) Shareholders Saw Their Shares Drop 59%

Simply Wall St

The Chemours Company (NYSE:CC) shareholders should be happy to see the share price up 25% in the last month. But that isn't much consolation to those who have suffered through the declines of the last year. During that time the share price has sank like a stone, descending 59%. It's not that amazing to see a bounce after a drop like that. Of course, it could be that the fall was overdone.

View our latest analysis for Chemours

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Unhappily, Chemours had to report a 36% decline in EPS over the last year. The share price decline of 59% is actually more than the EPS drop. So it seems the market was too confident about the business, a year ago. The less favorable sentiment is reflected in its current P/E ratio of 4.54.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

NYSE:CC Past and Future Earnings, September 23rd 2019

It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. That said, we think earnings and revenue growth trends are even more important factors to consider. It might be well worthwhile taking a look at our free report on Chemours's earnings, revenue and cash flow.


What about the Total Shareholder Return (TSR)?

Investors should note that there's a difference between Chemours's total shareholder return (TSR) and its share price change, which we've covered above. The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. Chemours's TSR of was a loss of 57% for the year. That wasn't as bad as its share price return, because it has paid dividends.

A Different Perspective

Over the last year, Chemours shareholders took a loss of 57% , including dividends . In contrast the market gained about 3.0%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Fortunately the longer term story is brighter, with total returns averaging about 5.7% per year over three years. The recent sell-off could be an opportunity if the business remains sound, so it may be worth checking the fundamental data for signs of a long-term growth trend. It is all well and good that insiders have been buying shares, but we suggest you check here to see what price insiders were buying at.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.